Movement Alert｜Duality Biotherapeutics-B Falls 5.07% in Regular Trading, Biotech Sector Faces Broad Profit-Taking Pressure

Market Focus07-07

On July 7, Duality Biotherapeutics-B declined 5.07% in regular trading, trading at 213.4 HKD/share, with turnover of HKD 388 million. The pullback came after the stock posted substantial gains in prior sessions, including a 15.45% surge on July 2 and a 9.01% rise on July 6, driven by its Science and Technology Innovation Board IPO status advancing to inquiry stage and sustained ADC pipeline catalysts.

The broader biotech sector came under significant selling pressure, with multiple major names retreating in tandem. Within the Biotechnology sector, 3SBIO fell 6.94%, Akeso fell 4.51%, Innovent Bio fell 3.87%, BeiGene fell 3.57%, and SKB Bio fell 2.58%, reflecting widespread profit-taking across the industry following the sector's strong rally earlier in the week.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1108116756?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-07 15:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108116756","market":"us","top_or_hot":-1,"title":"Movement Alert｜Duality Biotherapeutics-B Falls 5.07% in Regular Trading, Biotech Sector Faces Broad Profit-Taking Pressure","media":"Market Focus","content":"<p><p>On July 7, Duality Biotherapeutics-B declined 5.07% in regular trading, trading at 213.4 HKD/share, with turnover of HKD 388 million. The pullback came after the stock posted substantial gains in prior sessions, including a 15.45% surge on July 2 and a 9.01% rise on July 6, driven by its Science and Technology Innovation Board IPO status advancing to inquiry stage and sustained ADC pipeline catalysts.</p><p>The broader biotech sector came under significant selling pressure, with multiple major names retreating in tandem. Within the Biotechnology sector, 3SBIO fell 6.94%, Akeso fell 4.51%, Innovent Bio fell 3.87%, BeiGene fell 3.57%, and SKB Bio fell 2.58%, reflecting widespread profit-taking across the industry following the sector's strong rally earlier in the week.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Duality Biotherapeutics-B Falls 5.07% in Regular Trading, Biotech Sector Faces Broad Profit-Taking Pressure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Duality Biotherapeutics-B Falls 5.07% in Regular Trading, Biotech Sector Faces Broad Profit-Taking Pressure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-07 15:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 7, Duality Biotherapeutics-B declined 5.07% in regular trading, trading at 213.4 HKD/share, with turnover of HKD 388 million. The pullback came after the stock posted substantial gains in prior sessions, including a 15.45% surge on July 2 and a 9.01% rise on July 6, driven by its Science and Technology Innovation Board IPO status advancing to inquiry stage and sustained ADC pipeline catalysts.</p><p>The broader biotech sector came under significant selling pressure, with multiple major names retreating in tandem. Within the Biotechnology sector, 3SBIO fell 6.94%, Akeso fell 4.51%, Innovent Bio fell 3.87%, BeiGene fell 3.57%, and SKB Bio fell 2.58%, reflecting widespread profit-taking across the industry following the sector's strong rally earlier in the week.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09606","symbol_name":"映恩生物-B","start_time":0,"source_url":"","article_id":"1108116756","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108116756","pubTimestamp":1783408787,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 7, Duality Biotherapeutics-B declined 5.07% in regular trading, trading at 213.4 HKD/share, with turnover of HKD 388 million. The pullback came after the stock posted substantial gains in...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09606":"映恩生物-B"},"translate_title":"动向提示|Duality Biotherapeutics-B常规交易跌5.07%生物科技板块面临广泛获利回吐压力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09606":1},"content_text":"On July 7, Duality Biotherapeutics-B declined 5.07% in regular trading, trading at 213.4 HKD/share, with turnover of HKD 388 million. The pullback came after the stock posted substantial gains in prior sessions, including a 15.45% surge on July 2 and a 9.01% rise on July 6, driven by its Science and Technology Innovation Board IPO status advancing to inquiry stage and sustained ADC pipeline catalysts.The broader biotech sector came under significant selling pressure, with multiple major names retreating in tandem. Within the Biotechnology sector, 3SBIO fell 6.94%, Akeso fell 4.51%, Innovent Bio fell 3.87%, BeiGene fell 3.57%, and SKB Bio fell 2.58%, reflecting widespread profit-taking across the industry following the sector's strong rally earlier in the week.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1108116756","isCrawlerRequest":true}